LONDON (Alliance News) - Hikma Pharmaceuticals PLC said Monday that Mazen Darwazah, its executive vice-chairman and chief executive officer for the Middle East and North Africa, has extended a pledge of Hikma shares as collateral for a loan to 700,000 shares from 400,000.
The transaction took place on Friday last week, Hikma said. Mazen Darwazah has an interest in 6.9 million Hikma shares, or 3.47% of the total, unchanged by the increased loan commitment.
Hikma shares were quoted Monday morning at 1,189.00 pence, down 11.00 pence or 0.9%.
By Tom Waite; thomaslwaite@alliancenews.com; @thomaslwaite
Copyright 2013 Alliance News Limited. All Rights Reserved.
Hikma Pharmaceuticals (HIK)